Delving into the Latest Updates on Mekos Laboratories AS with Synapse

Overview

The study is required by the FDA as part of a post-marketing commitment. The purpose of the study is to compare the reactivity of the TRUE Test quaternium-15 patch and a real use exposure.The subjects will wear the patch test for 48 hours and reading will be performed day 3 or 4. The use test will be applied from day 3 or 4 and untill reaction appears. Reactions from respectively TRUE Test and use test will be compared using the McNemar Change Test.

Start Date01 Apr 2006

Sponsor / Collaborator

Mekos Laboratories AS

EUCTR2005-002987-27-DK

/ Not yet recruitingPhase 4

An open single centre evaluation of the reactivity of the T.R.U.E TestTM Quaternium-15 patch and a real use exposure in subjects known to be allergic to Quaternium-15.

Start Date02 Sep 2005

Sponsor / Collaborator

Mekos Laboratories AS

NCT00132600

/ CompletedPhase 2

Clinical Evaluation of Bacitracin. A Phase II Dose-Response Study

The purpose of this study is to establish a concentration of a bacitracin-patch for diagnosing allergic contact dermatitis.

Start Date01 Apr 2005

Sponsor / Collaborator

Mekos Laboratories AS

100 Clinical Results associated with Mekos Laboratories AS

Login to view more data